Invasive, early Breast Cancer
Also known as: Invasive Early Breast Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB01217 | Anastrozole | A competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00990 | Exemestane | Not Available | Terminated | 1 |